Rafferty Asset Management, LLC Accelerate Diagnostics, Inc Transaction History

Rafferty Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.54 - $1.41 $130,404 - $340,499	-241,489 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.4 - $5.15 $44,550 - $163,883	-31,822 Reduced 11.64%	241,489 $348,000
Q4 2021 Feb 10, 2022	BUY	$4.27 - $6.97 $427,375 - $697,613	100,088 Added 57.78%	273,311 $1.43 Million
Q3 2021 Nov 10, 2021	SELL	$5.31 - $8.25 $97,061 - $150,801	-18,279 Reduced 9.55%	173,223 $1.01 Million
Q2 2021 Aug 10, 2021	SELL	$6.81 - $9.23 $940,120 - $1.27 Million	-138,050 Reduced 41.89%	191,502 $1.54 Million
Q1 2021 May 10, 2021	BUY	$7.99 - $15.0 $2.25 Million - $4.23 Million	281,974 Added 592.66%	329,552 $2.74 Million
Q4 2020 Feb 10, 2021	BUY	$7.04 - $11.7 $334,949 - $556,662	47,578 New	47,578 $361,000

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $168M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rafferty Asset Management, LLC with notifications on news.